By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sirna Therapeutics Inc. (Boulder, CO) 

2950 Wilderness Place

Boulder  Colorado  80301  U.S.A.
Phone: 303-449-6500 Fax: 303-449-6995



Company News
Targeted Genetics Corporation (TGEN) Acquires Rights to siRNA Development Program in Huntington's Disease From Sirna Therapeutics Inc. (Boulder, CO) (RNAI) 4/7/2008 6:58:59 AM
Targeted Genetics Corporation (TGEN) Announces Breakthrough Research By University of Iowa Collaborator10/19/2005 5:13:16 PM
Sirna Therapeutics (RNAI) Announces CFO Departure10/19/2005 5:13:10 PM
Sirna Therapeutics (RNAI) Appoints Dr. Keith Yamamoto To Chairperson Of SAB10/19/2005 5:13:06 PM
Sirna Therapeutics (RNAI) To Relocate Corporate Headquarters To San Francisco10/19/2005 5:12:56 PM
Sirna Therapeutics (RNAI) Announces Results From Interim Analysis Of Phase 1 Single Dose Trial With Sirna-027 In Patients With Age-Related Macular Degeneration10/19/2005 5:12:53 PM
Sirna Therapeutics (RNAI) To Present At Leerink Swann/MEDA Inaugural Health Care Conference10/19/2005 5:12:52 PM
Sirna Therapeutics (RNAI) To Present At Biotechnology Industry Organization (BIO) CEO & Investor Conference10/19/2005 5:12:48 PM
Sirna Therapeutics (RNAI) Granted Two Key Patents On Its RNA Interference Technology10/19/2005 5:12:48 PM
Sirna Therapeutics (RNAI) Reports 2004 Fourth Quarter And Full Year Financial Results10/19/2005 5:12:46 PM